Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Tran, Ngoc Huu, Chansinghakul, Danaya, Chong, Chia Yin, Low, Chian Yong, Shek, Lynette P., Luong, Chan Quang, Fargo, Carina, Wartel, T. Anh, Sun, Sunny, Skipetrova, Anna, Bouckenooghe, Alain
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://ncbi.nlm.nih.gov/pubmed/30724660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1578595
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars